In acute coronary syndrome (ACS) patients, those with MS were more likely to be female, have a history of percutaneous coronary intervention, and have a lower left ventricular ejection fraction and higher Thrombolysis in Myocardial Infarction (TIMI) score. Since the MS has a negative long-term impact on cardiovascular mortality and reinfarction in patients with ACS, it can be used as a marker of cardiovascular mortality in patients with ACS and aggressively targeted.
I honestly only know of DM having a negative impact on prognosis after ACS; same RRR for drugs, but a higher event rate. I have never read the same on metabolic syndrome.
Also, I would not abbreviate the metabolic syndrome as MS. For most people, MS stands for multiple sclerose.
Or Mitral Stenosis! Looking at some recent data, its not about the wholesome Metabolic syndrome as a factor, rather individual component of blood pressure, lipid and glycaemia that are stronger determinants of risk and prognosis
- Badges
- Science topic
- Similar topics
- Biological Science
- Physiology
- Physiological Processes
- Stress